about
The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patientsA cluster-randomized trial of a primary care informatics-based system for breast cancer screening.Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.Identifying primary care patients at risk for future diabetes and cardiovascular disease using electronic health records.Documentation of body mass index and control of associated risk factors in a large primary care network.Changes in glycemic control from 1996 to 2006 among adults with type 2 diabetes: a longitudinal cohort study.Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records.Establishing visit priorities for complex patients: A summary of the literature and conceptual model to guide innovative interventions.Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testingGenetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms.Implementing practice-linked pre-visit electronic journals in primary care: patient and physician use and satisfaction.Diabetes oral medication initiation and intensification: patient views compared with current treatment guidelines.Perceived impact of diabetes genetic risk testing among patients at high phenotypic risk for type 2 diabetes.Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease.Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug usersIndividualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care network.Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severityRandomized controlled trial of health maintenance reminders provided directly to patients through an electronic PHR.Should the insulin resistance syndrome be treated in the elderly?Prevalence of basic information technology use by U.S. physiciansClosing the gap: eliminating health care disparities among Latinos with diabetes using health information technology tools and patient navigators.Diabetes differentially affects depression and self-rated health by age in the U.S.Effects of an online personal health record on medication accuracy and safety: a cluster-randomized trial.New models of population management for patients with diabetes--using informatics tools to support primary care.Impact of literacy and numeracy on motivation for behavior change after diabetes genetic risk testing.Prevalence of elevated hemoglobin A1c among patients admitted to the hospital without a diagnosis of diabetesEffect of hospital admission on glycemic control 1 year after dischargeMammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care networkDiagnostic certainty as a source of medical practice variation in coronary heart disease: results from a cross-national experiment of clinical decision making.A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.Is certainty more important than diagnosis for understanding race and gender disparities?: an experiment using coronary heart disease and depression case vignettes.Genetic architecture of type 2 diabetes: recent progress and clinical implicationsAntiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoringUser-Centered Design of a Tablet Waiting Room Tool for Complex Patients to Prioritize Discussion Topics for Primary Care VisitsPractice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trialQuality of diabetes care in U.S. academic medical centers: low rates of medical regimen change.Clinical predictors of disease progression and medication initiation in untreated patients with type 2 diabetes and A1C less than 7%.How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.The decision to intensify therapy in patients with type 2 diabetes: results from an experiment using a clinical case vignette.
P50
Q28201491-2AAE40E3-7001-49FA-8116-DADE1B9BAFA7Q30497874-5313E7C1-A2D5-4AA3-AFEF-DB94A7E9884EQ33222149-0335E729-A779-49AF-BD10-1F05877AD2DEQ33505849-1A27EFFE-FF1D-4361-83D6-D83E18EF8847Q33518929-B06C6323-29F4-4F71-948F-5E95DD6FE6A1Q33599403-6ED398B1-4664-4D4E-B9AD-BEA9E9B99378Q33683650-6539CE8D-B216-4D5D-8CA4-7440E2C9FB78Q33759685-1CE1C56B-E4BB-442E-9819-5A38B3F048BAQ33779389-E7C56784-4D51-431D-8052-0929CF75CC3FQ34141398-A9626580-F3C8-43ED-AEE2-9BDB18D693D7Q34371748-A9FAFD7D-C548-407D-8920-F6C00FB2E204Q34553412-74DE186D-87CD-4EE4-B1D1-82D3CFAFC392Q34583225-02A64807-32A0-4B07-8EEF-66A698C01DF0Q34704025-28DA9C7E-42DB-4793-A71F-578EBDB0A5A8Q34743004-31EC439B-498D-420F-B3F7-FC5C80402852Q35587902-CCEA5E98-6C6C-4411-9E44-C9AD060D5507Q35634792-920519B9-EAD4-4D40-8CFA-CFFC82134543Q35649023-B406BC92-EA74-4C97-9100-58EEBFE95B5FQ35673800-5453EFE9-A92C-49B6-96C5-1E8EFDF21637Q35696328-B0FCE64E-1F75-4094-B90D-4ACFF11C61C9Q35874186-3E13661F-5FAE-42B6-B294-5FF9B77A6A49Q36047150-6F4C7F1A-691F-4821-B119-F7C65A35A5ADQ36175170-2728D9C8-26D6-4B5B-883D-DAF568FFB69EQ36689475-7188F260-D557-41F3-A242-0C6E06B71FA7Q36931432-2EA5DA36-A3F8-4339-ACC6-6A3332235998Q36971951-36E202A8-6892-4A61-B714-AC295F5A3E4BQ37102984-F9CAE1F0-C492-4D1D-A62F-496FD5120692Q37112775-DDFC8D32-466B-4A8A-9B7F-B947FAAFE957Q37127310-EEAF47E1-D706-4550-91B0-2A40CC39F71CQ37141328-67C0843B-B720-4BE0-8865-40D5BE7BE1F4Q37178219-D568EC26-991F-4BEB-84DB-306AD915E59EQ37189221-A93E511F-FFF6-4FB9-BA03-B134064A6FAFQ37217490-CBC2859F-1FD0-4738-B09F-595FA116DD77Q37293576-987F29FC-386D-4241-8093-E7DF58BC5094Q37312877-3908ACCD-C8BC-4E66-A79A-08ACD2E27B5DQ37312881-BB24FC42-45CD-4F1B-BFD1-25604EFF9519Q37312900-11F7BC3E-91F1-47FD-BB81-C24309B79495Q37312905-EEDAD1E6-762C-4B6A-8127-4B6A34763EADQ37324904-2BAD63BD-5334-488E-BE1C-3780135B55BBQ37453291-D6436AAF-D677-47B0-BFD9-908EE4FED42A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Richard W. Grant
@ast
Richard W. Grant
@en
Richard W. Grant
@es
Richard W. Grant
@nl
Richard W. Grant
@sl
type
label
Richard W. Grant
@ast
Richard W. Grant
@en
Richard W. Grant
@es
Richard W. Grant
@nl
Richard W. Grant
@sl
prefLabel
Richard W. Grant
@ast
Richard W. Grant
@en
Richard W. Grant
@es
Richard W. Grant
@nl
Richard W. Grant
@sl
P106
P1153
7402005952
P21
P31
P496
0000-0002-6164-8025